(Q43072825)

13 November 2017

title

Significant increase in systemic exposure of atorvastatin after biliopancreatic diversion with duodenal switch (English)

1 reference

13 November 2017

I B Skottheim

1

1 reference

13 November 2017

G S Jakobsen

2

1 reference

13 November 2017

K Stormark

3

1 reference

13 November 2017

H Christensen

4

1 reference

13 November 2017

J Hjelmesaeth

5

1 reference

13 November 2017

T Jenssen

6

1 reference

13 November 2017

A Asberg

7

1 reference

13 November 2017

R Sandbu

8

1 reference

13 November 2017

language of work or name

English

0 references

publication date

5 May 2010

1 reference

Clinical Pharmacology & Therapeutics

13 November 2017

published in

1 reference

13 November 2017

volume

87

1 reference

13 November 2017

issue

6

1 reference

13 November 2017

page(s)

699-705

1 reference

Trends in bariatric surgical procedures.

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Clinical application of laparoscopic bariatric surgery: an evidence-based review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Duodenal switch provides superior weight loss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

First-pass metabolism of midazolam by the human intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Cytochrome P450 3A: ontogeny and drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Transporters and their impact on drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Therapeutic implications of the MDR-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Localization of cytochromes P450 in human tissues: implications for chemical toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Expression of a multidrug-resistance gene in human tumors and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Gastric emptying is not affected by sleeve gastrectomy--scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Pharmacokinetics of tacrolimus and cyclosporine in short-bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

7 January 2021

P-glycoprotein increases from proximal to distal regions of human small intestine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

7 January 2021

Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

7 January 2021

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

7 January 2021

Sleeve gastrectomy-a "food limiting" operation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

7 January 2021

Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

7 January 2021

Gastrointestinal adaptation following small bowel bypass for obesity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

7 January 2021

Small-intestinal and colonic changes after biliopancreatic bypass for morbid obesity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

7 January 2021

Functional adaptation of the intestinal mucosal enzymes after jejunoileal bypass for morbid obesity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.32

7 January 2021

Identifiers

DOI

10.1038/CLPT.2010.32

1 reference

release_elernntcjfhonhfya3rsaubfve

13 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/elernntcjfhonhfya3rsaubfve

24 November 2022

mapped directly with Wikidata item

1 reference